United States · FDA National Drug Code directory

Aspirin, Doxylamine succinate, Phenylephrine bitartrate, and Dextromethorphan hydrobromide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0280-1430_4537434b-b3ba-1f30-e063-6394a90ab587
Product NDC
0280-1430
Form
TABLET, EFFERVESCENT
Composition / generic term
Aspirin, Doxylamine succinate, Phenylephrine bitartrate, and Dextromethorphan hydrobromide
Labeler
Bayer HealthCare LLC.
Marketing category
DRUG FOR FURTHER PROCESSING
Marketing start / end (source format)
20100801
Source listing expiry
20261231

Source-listed ingredients

  • ASPIRIN — 500 mg/1
  • DOXYLAMINE SUCCINATE — 6.25 mg/1
  • PHENYLEPHRINE BITARTRATE — 7.8 mg/1
  • DEXTROMETHORPHAN HYDROBROMIDE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1600 POUCH in 1 CASE (0280-1430-32) / 2 TABLET, EFFERVESCENT in 1 POUCH · 0280-1430-32

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Aspirin, Doxylamine succinate, Phenylephrine bitartrate, and Dextromethorphan hydrobromide — United States | Molindra Medicines